ACORN BIOVENTURES, L.P. - 06 Jan 2026 SCHEDULE 13G/A Report for Athira Pharma, Inc. Common Stock, $0.0001 Par Value (ATHA)

Filing Manager
ACORN BIOVENTURES, L.P.
Reporting Manager
Anders Hove
Security
Athira Pharma, Inc. Common Stock, $0.0001 Par Value
Symbol
ATHA
Shares outstanding
9,614,000 shares
Disclosed Ownership
596,068 shares
Ownership
6.2%
Form type
SCHEDULE 13G/A
Filing time
08 Jan 2026, 17:29:25 UTC
Date of event
06 Jan 2026
Previous filing
23 Dec 2025
SEC
View on sec.gov

Reporting Managers (5)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
ACORN BIOVENTURES, L.P. 2.6% 250,348 0 250,348 Anders Hove Manager of General Partner
ACORN CAPITAL ADVISORS GP, LLC 2.6% 250,348 0 250,348 Anders Hove Manager
ACORN BIOVENTURES 2, L.P. 3.6% 345,720 0 345,720 Anders Hove Manager of General Partner
Acorn Capital Advisors GP 2, LLC 3.6% 345,720 0 345,720 Anders Hove Manager
Anders Hove 6.2% 596,068 0 596,068 Anders Hove Individually